NEW YORK (GenomeWeb News) - Genomic technologies will be a focus of a new biotechnology hub being build in Puerto Rico, the island’s governor said today.
Calling the US territory a “Bio Island,” Anibal Acevedo Vilau said the molecular science facility would be a joint venture of the Puerto Rico, the US National Institutes of Health, and the University of Puerto Rico.
Along with genomics, the facility will study nanotechnology, biology, molecular neurosciences, and infectious disease prevention research.
The biotechnology hub will also include the University of Puerto Rico Cancer Center, a joint venture with the M.D. Anderson Cancer Center. The center will study cancer prevention and treatment specifically for the Hispanic community.
Puerto Rico also established the Science and Technology Trust to provide ongoing funding for infrastructure advancements and research and development projects.
Puerto Rico’s biotechnology sector has more than 2 million square feet of manufacturing space and has generated more than $3.5 billion in capital investments, the governor said.
The remarks were made as part of the second annual Biotechnology Week on Puerto Rico, which coincided with the third annual Caribbean and Latin American Biotechnology Congress.